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ABSTRACT Verapamil and amlodipine are calcium ion inﬂux inhibitors of wide clinical use. They are partially charged at neutral
pHandexhibit amphiphilic properties. Thenonchargedspecies caneasily cross the lipidmembrane.Wehavemeasuredwith solid-
state NMR the structural changes induced by verapamil upon incorporation into phospholipid bilayers and have compared them
with earlier data on amlodipine and nimodipine. Verapamil and amlodipine produce a rotation of the phosphocholine headgroup
away from themembrane surface and a disordering of the fatty acid chains.We havedetermined the thermodynamics of verapamil
partitioning into neutral andnegatively chargedmembraneswith isothermal titration calorimetry. Verapamil undergoesapK-shift of
DpKa¼ 1.2 units in neutral lipid membranes and the percentage of the noncharged species increases from 5% to 45%. Verapamil
partitioning is increased for negatively charged membranes and the binding isotherms are strongly affected by the salt
concentration. The electrostatic screening can be explained with the Gouy-Chapman theory. Using a functional phosphate assay
we havemeasured the afﬁnity of verapamil, amlodipine, and nimodipine for P-glycoprotein, and have calculated the free energy of
drugbinding from theaqueousphase to theactive center ofP-glycoprotein in the lipid phase.By combining the latter resultswith the
lipid partitioning data it was possible, for the ﬁrst time, to determine the true afﬁnity of the three drugs for the P-glycoprotein active
center if the reaction takes place exclusively in the lipid matrix.
INTRODUCTION
Broad-spectrum resistance to chemotherapeutic agents has
been termed multidrug resistance (MDR). Although several
mechanisms may contribute to MDR in mammalian cells, the
best characterized is the efﬂux or ﬂippase activity of the 170
kDa plasma membrane protein P-glycoprotein (Pgp, MDR1,
or ABCB1). Pgp binds its substrates in the cytosolic leaﬂet of
the lipid membrane and ﬂips them to the extracellular leaﬂet
or exports them to the extracellular environment (for review
see (2)). Substrate binding to Pgp is best described by a two-
step mechanism consisting of 1), a lipid-water partitioning
step followed by 2), a binding to the transporter in the lipid
phase (l) (3,4). The overall binding constant Ktw for the
binding from the aqueous phase (w) to the transporter (t) can
thus be expressed as product of the lipid-water partition co-
efﬁcient,Klw, and the transporter binding constant in the lipid
phase, Ktl (5). We measured the transporter-water binding
constant, Ktw, and the lipid-water partition coefﬁcient, Klw,
for several structurally different drugs and derived the corre-
sponding free energies of binding DG0tw and DG
0
lw. The free
energy of substrate binding to Pgp in the lipid membrane,
DG0tl, cannot be measured directly but was determined as the
difference DG0tl ¼ DG0tw  DG0lw (6). The value DG0tl can be
rationalized with a modular binding concept based on
hydrogen-bond formation (6–8).
The quantitative understanding of the two-step Pgp binding
mechanism is of importance for efﬁcient pharmacotherapy as
well as for drug design. We therefore have selected three
calcium channel blockers (verapamil, amlodipine, and
nimodipine) of chemically different structure but similar num-
bers of hydrogen-bond modules (Fig. 1) for a detailed ther-
modynamic and functional study. Verapamil (pKa 8.9 (9))
and amlodipine (pKa 8.6 (10)) are positively charged at pH
7.4 whereas nimodipine is electrically neutral. Using ther-
modynamic and spectroscopic techniques we examine the
partitioning of verapamil into phospholipid membranes and
compare it to previous studies on amlodipine and nimodipine
(11). The structure of the lipid membrane at different con-
centrations of verapamil was elucidated with solid-state NMR
methods using selectively deuterated lipids. The inﬂuence of
verapamil on the order of the lipid membrane is of special in-
terest since it was claimed that a decrease in membrane order
would reduce the activity of Pgp (for review, see (12,13)).
The thermodynamic results are correlated with a functional
assay for the binding of the three calcium-channel antago-
nists to Pgp in inside-out vesicles of MDR1-transfected
mouse embryo ﬁbroblasts (NIH-MDR1-G185) (14,15) and
compared to extracellular acidiﬁcation rate measurements
performed with living cells (6,16,17).
MATERIALS AND METHODS
Materials
Verapamil hydrochloride was purchased from Fluka Biochemika (Buchs,
Switzerland), amlodipine maleate from Sequoia Research Products
(Pangbourne, United Kingdom), and nimodipine from Sigma-Aldrich
(Sternheim, Germany). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
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(POPC), 1,2-dioleoyl-trimethylammonium-propane (DOTAP), and 1-palmitoyl-
2-oleoyl-sn-glycero-3-phosphoglycerol (POPG) were from Avanti Polar
Lipids (Alabaster, AL). All other chemicals were purchased at highest purity
from commercial sources.
Preparation of lipid vesicles
Small unilamellar vesicles (SUVs) of ;30 nm diameter were prepared as
follows. Deﬁned amounts of lipid were dissolved in chloroform and were
dried ﬁrst with a stream of N2 and then overnight under high vacuum. For
binary lipid mixtures the second lipid was added in chloroform solution to
the dried ﬁlm of the ﬁrst lipid and treated as before. Subsequently, buffer
solution (typically 50 mM HEPES, pH 7.4, plus various NaCl concentra-
tions) was added to the lipid ﬁlm and the mixture was vortexed extensively.
Next, the lipid dispersion was sonicated under a nitrogen atmosphere for
10–25 min (at 10C) until a clear solution was obtained. Metal debris from
the titanium tip was removed by centrifugation at 14,000 g for 10 min.
Cell lines and cell culture
The mouse embryo ﬁbroblast cell lines NIH3T3 and NIH3T3 transfected
with the human MDR1 gene, NIH-MDR-G185, were generously provided
by Dr. M. M. Gottesman, National Institutes of Health, Bethesda, MD. Cells
were maintained as described earlier (16,17). From these cells crude mem-
branes were prepared as described elsewhere (17,18).
NMR measurements
POPC was deuterated either at the a- or b-position of the choline headgroup
or at the cis-double bond of the oleic acyl chain (carbon atoms C-99, C-109)
(19,20),
POCH2 CH2N
a b
A deﬁned amount of deuterated lipid was transferred into a NMR sample
tube (typically 10–20 mg lipid) and drug/buffer solution was added to
achieve a predeﬁned drug/lipid ratio. For all NMR samples we used 25 mM
MES, pH 5.5, and 100 mM NaCl as buffer. The concentration of verapamil
was determined before mixing by UV spectroscopy at l ¼ 277 nm (e ¼
5818.8 M1 cm1). To achieve a homogeneous suspension, the sample was
extensively vortexed at room temperature with several freeze-thaw cycles in-
between. Centrifugation at 30,000 g for 60 min at room temperature led to a
clear supernatant. To calculate the molar amount of verapamil bound per
mol of POPC, Xb (mol/mol), the verapamil concentration in the supernatant
was determined again. A ﬂat baseline above 380 nm was used as a criterion
FIGURE 1 Chemical structures and
conformational models of three calcium
channel antagonists: verapamil, nimo-
dipine, and amlodipine. The three-
dimensional structures were obtained
by searching the most amphiphilic,
energy-minimized conformation with
the minimal cross-sectional area, AD.
Oxygen and nitrogen molecules are
shown in red and blue, respectively.
Hydrogen-bond acceptors, constituting
the binding modules for P-glycopro-
tein, are connected with dotted yellow
lines. Pgp does not accept secondary
amino groups (NHR) or NO2
groups (for details, see (7)).
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for complete lipid removal. All 2H-NMR experiments were performed on a
Bruker Avance 400 MHz spectrometer (Bruker AXS, Berlin, Germany).
2H-NMR spectra were recorded at 64 MHz with the quadrupole echo tech-
nique. The lipid pellets were used without further manipulations. 2H-NMR
spectra simulation was done with the NMR WebLab V.4.0 program (21).
31P-NMR spectra were recorded at 161 MHz using a Hahn echo sequence
with broadband proton decoupling (WALTZ-16) and a recycle delay of 6 s.
The chemical shielding anisotropy, Ds, was measured as full width at 10%
maximum intensity.
Isothermal titration calorimetry
Isothermal titration calorimetry was performed with a VP ITC instrument
(Microcal, Northampton, MA). Unless noted otherwise, measurements were
made at 37C. Appropriate buffer solutions were freshly prepared and the
pH was properly adjusted when the temperature was changed. The sample
cell contained the verapamil solution at a concentration of typically 100 mM.
Lipid vesicles suspended in the same buffer as verapamil (lipid concentra-
tion of ;25–30 mM) were placed in a 300 mL syringe. Five microliter in-
jections were made every 5 min. As a control, lipid vesicles were injected
into the calorimeter cell containing buffer without verapamil.
Analysis of the ITC data
The classical way to describe drug partitioning into the lipid phase is to use
the bulk concentration, CD,eq. Here CD,eq is the equilibrium drug concentra-
tion far from the membrane surface. The amount of bound drug, Xb ¼
nD=n
0
L, is then given by
Xb ¼ KCD;eq: (1)
Here nD is the molar amount of bound drug and n
0
L is the total lipid available
for binding (for charged drugs that cannot permeate the lipid membrane, n0L
is the lipid on the outer vesicle surface). This simple partitioning law is valid
for neutral drug molecules such as nimodipine. A more complex situation is
encountered for charged drugs as the adsorption of the cationic amphiphiles
leads to a positive surface potential c, repelling ions of like charge. Al-
ternatively, the membrane may contain negatively charged lipids, producing
a negative surface potential. Under these conditions, drug binding is in-
creased because of electrostatic attraction. In both cases, the drug concen-
tration at the plane of binding,CD,M, is not identical to the bulk concentration,
CD,eq, but is given by
CD;M ¼ CD;eqezDcF0=RT; (2)
where zDF0 is the molar electric charge, and RT is the thermal energy. The
partition equilibrium Eq. 1 can then be modiﬁed as
Xb ¼ KpCD;M: (3)
Electrostatic attraction/repulsion effects are thus explicitly taken into ac-
count. Equation 3 predicts a linear relationship between the extent ofmembrane-
bound drug and the drug surface concentration. Comparison with Eq. 1
demonstrates that K is not constant for charged drugs but depends on the
surface potential and the effective charge according to K ¼ KpezF0c=RT.
Consequently, K varies with the drug and salt concentration. For a mono-
valent drug such as verapamil and anionic POPC/POPG (75:25 mol/mol)
membranes in 0.1 M NaCl, K is typically 5–10 times larger than Kp
(verapamil concentration is in the mM-range). The surface potential, c, can
be evaluated with the Gouy-Chapman theory (22,23) and the details of this
analysis have been described previously (11,24). The analysis includes the
binding of Na1 ions to phosphatidylglycerol using the Langmuir adsorption
isotherm with a Na1 binding constant of 0.6 M1. In this evaluation the
HEPES buffer was counted as a 1:1 salt. The sulfonic acid has a pKa ; 3.6
(25) and is fully charged; the counterion is Na1. The piperazin ring is 50%
charged. This latter effect was not included.
Surface activity measurements
Surface activity measurements were performed at ambient temperature and
pH 7.4 (50 mMTris buffer, 114 mMNaCl) (26,27). Due to the low solubility
of amlodipine and nimodipine in water, stock solutions were prepared in
methanol. The total concentration of methanol in the Langmuir trough was,
however, ,5% v/v. The surface activity was corrected for the effect of
methanol. Despite this correction, the surface activity of charged drugs dis-
solved in methanol tends to be slightly higher than that of drugs dissolved in
water due to a small pKa shift. To obtain comparable experimental conditions,
verapamil was also injected as methanolic stock solution, despite its better
water solubility.
Pgp-ATPase activation assay
The P-glycoprotein associated ATPase activity was measured according to
Litman et al. (15) in a 96-well microtiter plate. The ATPase assay buffer
contained 25 mM Tris-HCl, 50 mM KCl, 3 mM ATP, 2.5 mM MgSO4,
3 mM DTT, 0.5 mM EGTA, 2 mM ouabain, and 3 mM sodium azide, where
the latter three compounds were used to inhibit the Ca-, the Na/K-, and the
mitochondrial ATPase, respectively. The assay buffer was adjusted to pH
7.4 at 37C. Membrane vesicles were diluted to a protein concentration of
0.1 mg/ml in ice-cold ATPase assay buffer. Each series of experiments
contained 5 mg protein in a total assay volume of 60 ml. Incubation with the
various drugs was started by transferring the plate from ice to a water bath,
where it was kept 1 h at 37C. The reaction was terminated by rapidly cool-
ing the plate on ice. The released inorganic phosphate was determined by
adding to each well an ice-cold stopping medium (200 ml) containing the
color reagent (sulfuric acid 1.43% v/v; and SDS, 0.9% w/v), ammonium
molybdate (0.2% (w/v)), and freshly prepared ascorbic acid (1% (w/v))).
After incubation at room temperature for 30 min, the released phosphate was
quantiﬁed calorimetrically at 820 nm using a microplate reader Spectramax
M2 (Molecular Devices, Sunnyvale, CA). To determine the vanadate-sensitive
PgpATPase activity, control samples were incubated in parallel with 500mM
vanadate and the values were subtracted from the values of the Pgp ATPase
activationmeasurements. For stock solutions,drugsweredissolved inDMSO.
The DMSO content of the sample was 1.67% (v/v). The data were analyzed
according to the model proposed by Litman et al. (15),
Vsw ¼ K1K2Vbas1K2V1Csw1V2C
2
sw
K1K21K2Csw1C
2
sw
; (4)
where Vsw is the rate of Pi release as a function of Csw, the substrate con-
centration in aqueous solution; Vbas is the basal activity of Pgp in the absence
of drug; V1 is the maximum transporter activity (if only activation occurred);
and V2 is the minimum activity at inﬁnite substrate concentration. At a
substrate concentration, Csw ¼ K1, half-maximum binding of the activating
binding region is reached and at a substrate concentration, Csw ¼ K2, half-
maximum binding of the inhibitory binding region is reached.
RESULTS
Verapamil-induced structural changes of
the lipid bilayer
Fig. 2 shows 2H-NMR spectra obtained with coarse lipo-
somes composed of POPC, deuterated at the a-segment of
the choline moiety (POCD2CH2N) and measured in
buffer at pH 5.5. Under these conditions, verapamil carries a
charge of z ¼ 11 (pKa 8.9, at 25C (9)).
All spectra are characteristic of liquid crystalline bilayers
with a single quadrupole splitting seen at all drug concen-
trations. A single, time-averaged quadrupole splitting is also
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found for the b-segment of the choline headgroup and the
cis-double bond of the oleic acyl chain (carbon atoms C-99,
C-109). Apparently, themobility of verapamil in the lipidmem-
brane is fast enough so that the presence of the drug is sensed
by all lipids in the bilayer within 105 s even at low drug con-
centration. The quadrupole splitting, DnQ, which is deﬁned
as the separation of the two most intense peaks in the deu-
terium NMR spectrum, is gradually changed as the molar
verapamil/POPC ratio increases. The quadrupole splittings
of the labeled carbon atoms are plotted in Fig. 3 as a function
of bound drug, Xb (mol drug bound per mol lipid), revealing
a linear relationship between the two parameters. For the two
headgroup segments, linear regression analysis yields
DnQðaÞ ¼ 6:45 46:14XbðkHzÞ (5)
and
DnQðbÞ ¼ 5:51 15:3XbðkHzÞ: (6)
Fig. 2 also demonstrates that the quadrupole splitting of the
a-segment collapses to a single line at a mole fraction of;Xb
; 0.14. The bilayer structure remains, however, unchanged
as evidenced by the phosphorus-31 NMR spectra shown next
to the corresponding deuterium NMR spectra. The phos-
phorus-31 NMR spectra with and without verapamil are very
similar and exhibit the typical signature of the bilayer phase
(28). The chemical shielding anisotropy is Ds ¼ 47.9 ppm
and remains approximately constant in the concentration
range investigated. From the shape of the phosphorus-31NMR
spectra it can be concluded that the long-range structure of
the bilayer remains unaltered. The deuterium NMR spectra,
on the other hand, provide evidence for a change in the orient-
ation of the choline dipole.
The verapamil-induced orientational change of the phos-
phocholine headgroup can be speciﬁed in more detail. Bind-
ing of the cationic verapamil to neutral POPC membranes
imparts a positive electric charge onto the membrane surface.
The orientation of choline headgroup P-N1 vectorwith respect
to the membrane surface is, however, dependent on the mem-
brane surface charge density (29). In particular, a positive
surface charge moves the N1 end of the P-N1 dipole toward
the water phase. This change in orientation entails a counter-
directional response of the quadrupole splittings of the
a- and b-segment such that DnQ(a) decreases and DnQ(b)
increases. Indeed, this counterdirectional change of the quad-
rupole splitting of the two choline segments is also observed
for verapamil (Fig. 3). The extent of the out-of-plane rotation
cannot yet be quantitated but exceeds that induced by
amlodipine (11) or other monovalent hydrophobic drugs
when applied at a similar membrane concentration (30).
The inﬂuence of verapamil on the hydrophobic part of the
bilayer membrane was also examined with deuterium NMR.
The deuterium labels were attached to the cis-double bond
(C-99 andC-109 segment) of the sn-2 oleic acyl chain of POPC.
FIGURE 2 Deuteriumandphosphorus-31NMRspectra ofPOPC liposomes
deuterated at the a-position of the choline headgroup (POCD2CH2N1).
Approximately twenty-ﬁve milligrams of POPC was suspended in 50 mL
buffer (25 mM, MES 0.1 M NaCl, pH 5.5, deuterium-depleted water) con-
taining different concentrations of verapamil. The two top spectra correspond
to pure POPC membranes without verapamil. The spectra below are char-
acterized by increasing drug concentrations. The verapamil/POPCmolar ratio
from top to bottom is: 0, 0.02, 0.04, 0.07, 0.11, and 0.14. Virtually all
verapamil is incorporated into the membrane. (Number of FIDs: 2H NMR
spectra 8 K, 31P NMR 2 K.)
FIGURE 3 Variation of the deuterium NMR quadrupole splittings of
POPC membranes with the verapamil/lipid molar ratio. (A) Phosphocholine
headgroup segments: (n) a-CD2 POPC (POCD2CH2N); (d) b-CD2-
POPC (POCH2CD2N1). (B) POPC deuterated at the cis-double bond of
the oleic acyl chain: (n) C-99 deuteron, (d) C-109 deuteron. Measurements
at 22C in buffer (MES 25 mM 1 0.1 M NaCl, pH 5.5).
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The two deuterons give rise to two separate quadrupole
splittings with separations of 13.5 (C-99) and 2.3 kHz
(C-109), even though they are connected to the same rigid
structure (see Fig. 4). The molecular origin of this effect is a
tilting of the cis-double bond with respect to the bilayer
normal (20).
The variation of these quadrupole splittings with the mole
fraction of bound verapamil is included in Fig. 3. The quad-
rupole splittings of both deuterons are moderately decreased
upon increasing the verapamil concentration, according to
DnQðC-99Þ ¼ 11:5Xb1 13:65 ðkHzÞ (7)
and
DnQðC-109Þ ¼ 21:9Xb1 2:3 ðkHzÞ: (8)
The fact that both quadrupole splittings decrease simulta-
neously suggests a disordering of the hydrophobic core upon
verapamil intercalation, that is, a more random motion of the
cis-double bond. This is quite different from amlodipine and
nimodipine, which induce a small increase in the C-99 and
C-109 quadrupole splittings (11).
Fig. 4 illustrates a second effect induced by the incorpo-
ration of verapamil into the lipid bilayer but limited to the
hydrophobic region. All spectra in Fig. 4 were measured
under identical conditions, in particular, the same number of
free induction decays. Inspection of Fig. 4 nevertheless reveals
a loss in signal intensity with increasing amount of verapamil
in the membrane, which can be quantiﬁed by spectral sim-
ulation (smooth lines in Fig. 4). The spectrum with the lowest
verapamil concentration serves as a reference spectrum and
the areas under the two quadrupole splittings of this spectrum
are identical (1:1 intensity ratio, Fig. 4, lower panel). At the
highest verapamil concentration (Xb ¼ 0.43) the intensity of
the C-109 deuteron is still 83% of the initial intensity; that of
the C-99 deuteron, however, is reduced to 33%. The most
likely explanation of this effect is a reduction in the rate of
motion of the cis-double bond caused by a weak complex
formation with the aromatic ring system of verapamil. The
reduced rate of motion makes the refocusing of the quad-
rupole echo more difﬁcult, particularly for large quadrupole
splittings. Similar effects have been observed for amlodipine
in POPC membranes (11) and for reconstituted lipid-protein
systems such as sarcoplasmic reticulum membranes, cyto-
chrome c-oxidase, and rhodopsin (31–33). No intensity losses
are observed for the a- and b-segments of the choline head-
group, indicating that the dynamics of the headgroup is not
affected by the presence of verapamil.
Verapamil binding to lipid bilayers: variation of
salt concentration and membrane charge
The adsorption of charged, amphipathic molecules to mem-
branes involves electrostatic and hydrophobic interactions,
protonation reactions, and dehydration effects. They contrib-
ute, to differing extent, to the heat measured in an isothermal
titration calorimetry (ITC) experiment. As an example, Fig. 5
shows the titration of a 100 mM verapamil solution in buffer
(50 mM HEPES, 50 mM NaCl, pH 7.4) with sonicated lipid
FIGURE 4 2H-NMR spectra of POPC membranes deuterated at the cis-
double bond of the sn-2-oleic acyl chain and suspended in buffer with
various verapamil concentrations. Approximately twenty-ﬁve milligrams of
lipid suspended in 50 mL buffer (MES 25 mM1 0.1 M NaCl, pH 5.5) were
used. The verapamil/lipid molar ratios from bottom-to-top are 0.003, 0.021,
0.037, and 0.048. The smooth lines are the simulated deuterium NMR
spectra. The lower panel shows the loss in signal intensity of the C-99 and
C-109 deuteron as a function of the verapamil/lipid molar ratio referenced to
the pure POPC spectrum. The C-99 deuteron with a 13 kHz splitting shows a
much steeper intensity loss than the C-109 deuteron with a 2 kHz splitting.
(4 K free induction decays for all spectra.)
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vesicles composed of POPC/POPG (75/25 mol/mol). Ve-
rapamil is contained in the calorimeter cell (Vcell ¼ 1.4037
mL) while the lipid suspension is injected at 5 mL aliquots.
The total lipid concentration is 25 mM. Each lipid injection
causes an exothermic binding reaction as revealed by the
heat ﬂow in Fig. 5 A. The size of the titration peak becomes
smaller with increasing number of injections as less and less
verapamil is available for binding. The integration of the heat
ﬂow peaks yield the heats of reaction, hi, and Fig. 5 B dis-
plays the cumulative heat of reaction, Shi, as a function of
the injection number i.
Fig. 5 further demonstrates that the reaction comes to com-
pletion after n ; 30 injections. The molar binding enthalpy,
DH0D, can then be calculated according to
DH
0
D ¼ +
n
i¼1
hi=n
0
D; (9)
where n0D is the total molar amount of verapamil in the
calorimeter cell. Fig. 6 and Table 1 summarize the binding
enthalpies,DH0D, of verapamil binding to POPC/POPG, POPC,
and POPC/DOTAP membranes, as a function of total salt
concentration (at 37C). HEPES buffer was treated as a mono-
valent salt.
For negatively charged POPC/POPG vesicles the binding
enthalpy is almost independent of the salt concentration and
averages to DH0D ¼ 2:860:5 kcal=mol. Neutral POPC and
cationic POPC/DOTAP vesicles have DH0D values in the
range of 0.4 to 1.1 kcal/mol, which decrease with in-
creasing salt concentration. At salt concentrations ,50 mM
for POPC and ,75 mM for POPC/DOTAP (95:5 mol/mol),
no heat of reaction could be observed. Also, no drug binding
could be measured when the DOTAP molar percentage was
raised above 10 mol %.
It is possible to deduce the amount of bound drug directly
from the calorimetric titration according to
n
ðiÞ
D;bound ¼ +
i
k¼1
hk=ðDH0DVcellC0DÞ; (10)
where n
ðiÞ
D;bound is the molar amount of bound drug after i injec-
tions, +i
k¼1 hkis the cumulative heat of the ﬁrst i injections,
Vcell is the volume of drug solution in the calorimeter cell,
and C0D is the total drug concentration. The amount of free
drug is then given from mass conservation as
nðiÞD;free ¼ n0D  nðiÞD;bound: (11)
The degree of binding was deﬁned above as
X
ðiÞ
b ¼ nðiÞD;bound=gn0L; (12)
where n0L is the total molar amount of lipid and gn
0
L is the
fraction of lipid accessible to the drug. It is hence possible
to deduce the complete binding isotherm Xb ¼ f (ceq) from
the calorimetric titration without invoking a speciﬁc binding
model.
For POPC/POPG vesicles at pH 5.5, n0L is only 60% of the
total lipid (g ¼ 0.6), since the drug is fully charged and cannot
translocate across the membrane. For all other measurements
FIGURE 5 Titration of a 100 mM verapamil solution in 50 mM HEPES,
pH 7.4 with 30 nm unilamellar lipid vesicles in the same buffer. Lipid
composition is POPC/POPG (75:25 mol/mol). The injection of the lipid
vesicles was in 5 mL steps. Measuring temperature 37C. (A) Heat ﬂow and
(B) cumulative heat of reaction as a function of injection number.
FIGURE 6 Reaction enthalpies of verapamil binding to phospholipid
vesicles (30 nm) of different lipid composition. Variation of the binding
enthalpy, DH0D, with the salt concentration. (n) POPC/POPG 75:25 mol/mol,
(d) pure POPC, and (n) POPC/DOTAP 95:5 mol/mol.
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described in this study, a rapid translocation of verapamil
across the membrane was assumed (g ¼ 1). For example,
POPC/POPG vesicles at 150 mM salt and pH 7.4 exhibit a
surface potential of ;30 mV, which reduces the pH near
the membrane surface to pH 6.8. At this pH, the neutral form
of verapamil accounts for only 1% of the total drug con-
centration. However, upon entering the membrane, verapa-
mil experiences a pKa shift by 1.2 units (see below). Both
effects together are sufﬁcient to establish a rapid trans-
membrane equilibrium.
Fig. 7 then displays ITC-derived binding isotherms for
POPC/POPG bilayers at various salt concentrations. The
strongest binding is observed for the lowest salt concentra-
tion where the electrostatic attraction between the anionic
membrane and the cationic drug is maximal. All binding iso-
therms have a curved appearance and the binding constant
deﬁned according to Eq. 1 varies with the verapamil and salt
concentration. At a verapamil concentration of CD,eq ¼ 10
mM, apparent binding constants are K ; 4 3 103 M1. In
contrast, the solid lines in Fig. 7 were calculated with the
Gouy-Chapman theory and a common binding constant
Kp¼ 4106 30M1 describes all three binding isotherms over
thewhole concentration range. The valueKp refers to the bind-
ing of the charged form of verapamil. Table 1 summarizes
the Kp values for the different systems investigated. The
value Kp is distinctly smaller than the apparent binding
constant K, since the electrostatic attraction is not included.
For neutral POPC and cationic POPC/DOTAP vesicles at
pH 7.4, the pH increases near the membrane surface and the
fraction of the neutral form also increases. Membrane trans-
location of the drug is thus easily possible. Fig. 8 shows
binding isotherms for POPC SUVs (three different salt con-
centrations) and for POPC/DOTAP SUVs. The extent of
drug binding to POPC and POPC/DOTAP SUVs is clearly
smaller than that observed for POPC/POPG SUVs at the same
salt concentration. Electrostatic attraction/repulsion is the
dominant factor for verapamil binding to charged membranes.
For anionic POPC/POPG membranes the electrostatic
FIGURE 7 Verapamil binding isotherms for POPC/POPG membranes
(75:25 mol/mol) at three different salt concentrations. All measurements
made at pH 7.4 and 37C. 50 mM HEPES1 50 mM NaCl; 50 mM HEPES;
and 25 mM HEPES. The solid lines were calculated with the partition
constants, Kp, given in Table 1 and the Gouy-Chapman theory. A rapid
translocation of the neutral form of verapamil across the membrane was
assumed.
TABLE 1 Thermodynamics of verapamil binding to phospholipids bilayer vesicles of different charge and size
SUV
30 nm
POPC
mol %
POPG
mol %
HEPES
mM
NaCl Drug electric charge near
membrane surface Æzæ DH0D kcal=mol Kp M
1 DG0D kcal=mol
75 25 50 100 0.84–0.89 3.2 520 3.84
75 25 50 50 0.87–0.93 2.1 400 3.75
75 25 50 25 0.88–0.94 2.8 450 3.75
75 25 50 0 0.91–0.96 3.3 300 3.50
80 20 25 0 0.91–0.97 2.5 380 3.65
80 20 5 0 0.96–0.99 2.9 330 3.56
100 50 100 0.57–0.63 1.1 900 4.18
100 50 50 0.57–0.62 0.9 800 4.1
100 50 25 0.53–0.61 0.4 1200 4.35
TRIS
100 50 100 0.59–0.64 3.1 900 4.18
PO4
100 50 100 0.59–0.64 11.4 750 4.06
DOTAP HEPES
94.2 5.8 50 100 0.49–0.51 1.1 500 3.81
LUV
100 nm 100 50 100 0.61–0.64 1.0 470 3.78
100 50 50 0.61–0.63 1.1 400 3.68
100 50 25 0.59–0.63 0.6 500 3.81
Note that all measurements are at 37C, pH 7.4.
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interaction is favorable, for cationic POPC/DOTAP mem-
branes it is repulsive. However, even for neutral membranes,
electrostatics is important since the membrane surface
becomes positively charged as soon as the ﬁrst cationic
drug molecule is incorporated into the membrane. Further
binding of drug molecules thus becomes increasingly more
difﬁcult. The solid lines in Fig. 8 were again calculated with
the Gouy-Chapman theory.
The results described above were obtained with vesicles
prepared by sonication, having an average diameter of ;30
nm (SUV). Verapamil binding to POPC membranes was also
studied with unilamellar vesicles of 100 nm diameter (LUVs)
prepared by extrusion through polycarbonate ﬁlters. LUVs
exhibit a tighter lipid packing than SUVs and resemble more
closely planar lipid bilayers. The ITC data were analyzed
with the same model as described for SUVs. Again fast
translocation of the drug (in its uncharged form) across the
membrane was assumed. The experimental results are in-
cluded in Table 1. The reaction enthalpy at 37C is DH0D ¼
1:1 kcal=mol for SUVs and DH0D  1:0 kcal=mol for
LUVs. The binding constants, again deduced with the Gouy-
Chapman theory, are somewhat smaller than those of SUVs
(see Table 1).
Membrane-induced pKa shift of verapamil
The ionization constant of verapamil in aqueous solution at
25C is pKa 8.9 (9). It is temperature-dependent and decreases
with increasing temperature (see below). A decrease in pKa
can also be expected for verapamil entering the lipid mem-
brane, because the neutral form is favored in the nonpolar
environment. The pKa shift was quantiﬁed by measuring the
binding reaction in buffers of different dissociation en-
thalpies, since the reaction enthalpy is the sum of the ve-
rapamil deprotonation and the buffer protonation. Verapamil
binding to POPC vesicles yields DH0D ¼ 3:0 kcal=mol in
50mMTris buffer,DH0D ¼ 1:1 kcal=mol in 50mMHEPES
buffer, and DH0D ¼ 11:4 kcal=mol in phosphate buffer (all
measurements at 100 mM NaCl, pH 7.4). This provides
evidence for a deprotonation reaction (34–36) of verapamil
as it enters the membrane. Fig. 9 shows a plot of the binding
enthalpy, DH0D, versus the buffer dissociation enthalpy,
DHbuffer, yielding
DH
0
D ¼ 0:41DHbuffer1 1:5: (13)
From the slope it can be deduced that 0.41 H1 dissociate
upon verapamil insertion into the neutral POPC membrane.
While the average charge of verapamil in solution at pH 7.4
is ÆzDæ ¼ 0.97 e.u., the membrane-bound drug carries an
average charge of ÆzDæ  0.56 e.u. The reduction by dz ¼
0.41 e.u. can be traced back to two sources. Upon binding to
the membrane, verapamil repels H1 ions from the membrane
surface. At 150 mM salt and 0.1 mM verapamil, the pH at the
membrane surface increases to ;pH 7.6 and the electric
charge of verapamil decreases concomitantly to z¼ 0.95 e.u.
(dz ¼ 0.02 e.u.). However, from the buffer dependence one
deduces a much larger change of dz¼ 0.41 e.u., attesting to a
FIGURE 8 Binding of verapamil to POPC SUVs and mixed POPC/
DOTAP (94.2:15.8 mol/mol) SUVs at various salt concentrations. (s) Pure
POPC SUVs; (h) POPC/DOTAP SUVs. All measurements in 50 mM Tris
or HEPES buffer 1 various concentrations of NaCl at 37C: The solid lines
are theoretical binding isotherms calculated with the partition coefﬁcients
listed in Table 1.
FIGURE 9 Variation of the verapamil binding enthalpies with the buffer
dissociation enthalpies. POPC vesicles with 30 nm diameter. Measurements
made in Tris (DHDiss ¼ 11.51 kcal/mol), HEPES (DHDiss ¼ 4.9 kcal/mol),
and phosphate (DHDiss ¼ 1.22 kcal/mol) at 37C (36).
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pKa shift as the drug enters the hydrophobic environment. At
pH 7.6, a pKa shift from pKa; 8.9 to pKa; 7.7 reduces the
charge from Æzæ ¼ 0.95 to z ¼ 0.56 (dz ¼ 0.39). The two
effects together (pH change plus pKa shift) then explain the
experimental data. Based on chemical equilibria consider-
ations it can be calculated that the uncharged drug has a
10DpKa;16-times higher partition-coefﬁcient for the lipid
membrane than the protonated species. The binding constant
of uncharged verapamil is thus Kp ¼ 6.5 3 103 M1 for
POPC/POPG membranes and Kp ; 1.6 3 10
4 M1 for
POPC vesicles (at pH 7.4 and 37C).
For membranes composed of diphytanoyl PC, a dissoci-
ation constant for uncharged verapamil was estimated as
Kd ¼ 0.061 6 0.01 mM at pH 10.5 based on electrophoretic
and membrane potential measurements (37). This translates
into a binding constant of Kp ¼ 1.6 3 104 M1.
We also measured the molar reaction enthalpy of verap-
amil binding to POPC vesicles at pH 5.5. At this pH,
verapamil is fully charged and no deprotonation takes place
upon binding to the membrane. The binding enthalpy was
found to be DH0DðpH 5:5Þ ¼ 2:7 kcal=mol. On the other
hand, the (extrapolated) binding enthalpy at pH 7.4 in the
absence of a buffer dissociation reaction is DHD (pH 7.4) ¼
1.5 kcal/mol (see Fig. 9 for DHDiss¼ 0). The value DHD (pH
7.4) is thus composed of the binding enthalpy of the fully
charged drug, DHD (pH 5.5), plus the dissociation enthalpy
for 0.41 H1,
DHDðpH 7:4Þ ¼ DHDðpH 5:5Þ1 0:41DHNHDiss; (14)
where DHNHDiss is the dissociation enthalpy of the verapamil
amino group. The latter is then calculated as DHNHDiss ¼
10:2 kcal=mol. This result is consistent with data obtained
for N-terminal amino group of peptides where the dissoci-
ation energy is ;11 6 2 kcal/mol (38).
Heat capacity change DCP
0
We have measured the temperature-dependence of the
verapamil-membrane partition equilibrium. For PC/PG
(75:25 mol/mol) membranes in 50 mM HEPES at pH 7.4,
DH0D shows only a small temperature-dependencewith amolar
heat capacity of DC0P ¼ 14 cal=molK. For pure PC SUVs in
buffer (100 mM NaCl, 50 mM HEPES, pH 7.4), the heat cap-
acity change is DC0P ¼ 12 cal=molK.
Molecular cross-sectional area and air-water
partition coefﬁcient
Amphiphilic molecules such as verapamil, amlodipine, and
nimodipine partition into the air-water and lipid-water inter-
face such that the polar groups remain in either the aqueous
phase (e  80) or the polar headgroup region of the lipid
membrane (e  30). The hydrophobic group is then exposed
to air (dielectric constant, e  1) or inserts into the lipid core
region (e  2). The approximate conformation of the three
Ca21 blockers, calculated by optimizing polar and nonpolar
interactions, are shown in Fig. 1 (39). The cross-sectional
areas of the three molecules, relevant for membrane inser-
tion, were calculated as AD ¼ 82 A˚2 for verapamil, 66.2 A˚2
for amlodipine, and 69.4 A˚2 for nimodipine.
The surface activities of the three Ca21 blockers were mea-
sured with the Wilhelmy plate method (data not shown) and
were described by the Szyszkowski isotherm. The measured
cross-sectional area of verapamil in aqueous solution is AD¼
82 6 2 A˚2 and in good agreement with the calculated value.
The cross-sectional areas of amlodipine (AD ¼ 122 A˚2) and
nimodipine (AD ¼ 87 A˚2) are, however, larger than the cal-
culated data, which is caused by association effects at higher
concentrations. For the following calculations, we use the
calculated cross-sectional areas.
The air-water partition coefﬁcients are KA/W ¼ 1.7 3 105
M1 for verapamil, KA/W ¼1.9 3 106 M1 for amlodipine,
and KA/W ¼ 7.1 3 105 M1 for nimodipine. Insertion into
the lipid bilayer expands the surface area and requires ad-
ditional expansion work pAD (40) where p is the monolayer-
bilayer equivalence pressure (41). The lipid-water partition
coefﬁcient can then be calculated from the air-water partition
coefﬁcient as KLip/W ¼ KA/W exp (p AD/kT) (26). For
POPC LUVs (100 nm) and planar membranes with an
equivalence pressure of p ; 30 mN/m, the lipid-water par-
tition coefﬁcient of charged verapamil is predicted to be
Klip/W  540 M1 in excellent agreement with the ITC
measurements. For amlodipine Klip/W¼ 1.83 104 M1, again
in good agreement with previous ITC measurements (Kp ¼
1.6 3 104 M1 at pH 7.2, (11)). For nimodipine, the lipid
water partition coefﬁcient was calculated as Klip/W ¼ 5.4 3
103 M1. This value must be considered as a lower limit as
nimodipine has a strong tendency to adsorb to the vessel walls.
The data are summarized in Table 2.
P-glycoprotein transporter activity measurements
with verapamil, amlodipine, and nimodipine
The P-glycoprotein transporter (Pgp) accepts its substrates
from the cytosolic membrane leaﬂet. The Pgp transport eff-
iciency is determined by 1), the lipid solubility of the sub-
strate; and 2), the afﬁnity of the substrate for the transporter
in the lipid phase. The latter can be estimated on the basis of
characteristic hydrogen-bonding patterns (6,7). Pgp shows
basal activity in the absence of substrates. In the presence of
substrates it follows a bell-shaped curve with an initial in-
crease in activation (characterized by the concentration of half-
maximum activation, K1) followed by a decrease in activa-
tion at higher drug concentrations (characterized by the
concentration of half-maximum inhibition, K2). The model is
detailed in references (6,15). Experimental results obtained
with inside-out vesicles using a phosphate assay are shown
in Fig. 10 for both verapamil and amlodipine. The quanti-
tative analysis in terms of the model described by Litman
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et al. (15) yields the parameters K1, K2 and also the cor-
responding reaction velocities V1 and V2. The data are
summarized in Table 2. As outlined previously, the param-
eters K1 and K2 can be interpreted as dissociation constants.
Table 2 reveals that amlodipine has a higher afﬁnity to Pgp
than verapamil during the activation phase. Whereas the in-
hibition phase can be well measured for verapamil it cannot
be measured to high concentrations for amlodipine and
nimodipine due to drug association in solution. Partitioning
into the lipid membrane requires the monomeric form of
drugs and is not possible at concentrations which are higher
than the critical micelles concentration.
DISCUSSION
Structural aspects of verapamil binding
Verapamil HCl is a calcium-ion inﬂux inhibitor of wide
clinical use. It is administered as a racemic mixture of R- and
S-enantiomers. At low drug concentration and pH 7.4, a neu-
tral (3%) and a charged species (97%) are in equilibrium in
aqueous solution. The molecule exhibits amphiphilic prop-
erties and is well soluble in water, organic solvents, and lipid
membranes. The pKa-value of verapamil decreases distinctly
with increasing temperature as the present ITC data show
that the dissociation enthalpy is endothermic with DHNHDiss;
10 kcal=mol.
Fig. 1 displays the conformations of verapamil, amlodip-
ine, and nimodipine in the lipid membrane obtained by an
energy minimization calculation (39). Verapamil adopts a
folded conformation such that both aromatic ring systems
can be inserted into the hydrophobic core of the membrane
whereas the charged amino group remains at the lipid-water
interface. Partitioning of verapamil into the lipid membrane
modulates the lipid bilayer structure, as evidenced by deu-
terium NMR. The predominant effect in the hydrocarbon
region is a disordering of the hydrocarbon chains and a weak
complex formation of the cis-double bond with the aromatic
rings of verapamil. Hydrocarbon chain disordering is a
common phenomenon when proteins or other nonlipid com-
ponents are inserted into the lipid bilayer (11,32). Particu-
larly effective are detergent molecules (42,43), whereas
cholesterol has the opposite effect; that is, the rodlike mol-
ecule induces a stiffening of the hydrocarbon chain (44–47).
Membrane disordering has been implied in Pgp inactivation
TABLE 2 Comparison of verapamil, amlodipine, and
nimodipine; bilayer structure, binding thermodynamics,
and P-glycoprotein activity
Nimodipine Amlodipine Verapamil
Deuterium NMR
Headgroup segments
ma (kHz/mol) no effect* 30.50* 46.14
mb (kHz/mol) no effect* 15.25* 15.30
cis-double bond
mC-99 (kHz/mol) 11.50
mC-109 (kHz/mol) 21.90
Surface activity
measurements
Cross-sectional area
AD (A˚
2) 69.4 66.2 82
KA/W (M
1)y 7.1 3 105z 1.9 3 106 1.7 3 105
Klip/w (M
1)
at 30 mN/m
5.4 3 103z 1.8 3 104 540
ITC measurements
Kp (M
1) LUVS nd 7.6 3 103§ 470{
DG0lwðkcal=molÞ 5.275 5.484 3.776
DH0 (kcal/mol) nd 8.90§ 1.0{
Max. electric charge 0 1 1
pK — 8.6 8.9
Pgp activity
K1 (M) 7.9 3 10
7 1.1 3 107 9.5 3 107
DG0twðkcal=molÞ 8.624 9.834 8.511
K2 (M) — 3.9 3 10
5 3.7 3 105
V1 (%) 2.06 2.13 2.6
Drug afﬁnity in
lipid bilayer
DG0tlðkcal=molÞ 3.35 4.350 4.735
Ktl (M
1) 234 1200 2240
No. of H-bond
acceptors
4 4 5
DG0HiðJ=molÞ 0.84 1.088 0.947
*Data taken from Ba¨uerle et al. (11).
yData obtained with methanolic stock solutions (see Materials and
Methods).
zLower limit due to adsorption to the Teﬂon trough.
§Multilamellar POPC liposomes, 0.1 M NaCl, 10 mM Tris, pH 7.25.
Ba¨uerle et al. (11) gives Kp ¼ 1.553 104 M1 and DH0 ¼ 8.9 kcal/mol at
23C. Using van9 t Hoff’s law and assuming a temperature-independent
DH0, Kp was recalculated for 37C.
{100 nm POPC LUVs, 0.1 M NaCl, 50 mM HEPES, pH 7.4, 37C.
FIGURE 10 Pgp activation proﬁles obtained by a phosphate release assay
with inside-out vesicles prepared from NIH-MDR-G185 cells. (n) Verap-
amil; (s) amlodipine.
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but cannot play an important role for verapamil as this mol-
ecule is considered as the substrate per-excellence for spe-
ciﬁc drug-Pgp interactions. At the headgroup level, verapamil
moves the 1N end of the choline dipole toward the water
phase. Verapamil is more efﬁcient than amlodipine in turning
the P-N1 dipole since the change of the DnQ(a) quadru-
pole-splitting-per-mole-incorporated drug is ma ¼ 46.1
kHz/mol for verapamil and onlyma¼30.5 for amlodipine.
Nimodipine as a noncharged molecule has no effect (11).
The consequence of this change in dipole orientation is a
change in the electric ﬁeld across the bilayer membrane. The
P-N1 dipole has a large dipole moment of;25 Debye (48).
If the P-N1 dipole is approximately parallel to the mem-
brane surface, as in a pure POPC bilayer (49), the electric
dipole ﬁeld cannot penetrate deeply into the membrane. An
orientation 20 away from themembrane surface can, however,
creates a ﬁeld of ;100 mV in the adjacent hydrophobic part
of the membrane with its low dielectric constant of e ¼ 2.
Dipole ﬁelds are not efﬁciently screened by salt and are thus
long-range. The electric effect of a single verapamil molecule
will therefore extend over several layers of surrounding phos-
pholipids. Electric ﬁelds of 100 mV across a distance of 2 nm
thickness correspond to a ﬁeld strength of 5 3 107 V/m and
can induce conformational changes in proteins.
Thermodynamic binding parameters
and Pgp activation
The extent of partitioning of verapamil into a lipid bilayer
membrane is inﬂuenced by the electric charge of the mem-
brane surface and the screening of Coulombic interactions
through inert electrolytes. This is illustrated with the binding
isotherms obtained for negatively charged (Fig. 7) and neutral
(Fig. 8) membranes. In both cases, increasing NaCl concen-
trations decrease the amount of bound verapamil. Negatively
charged POPC/POPG (75/25 mol/mol) membranes exhibit a
surface potential of 40 mV in 150 mM NaCl, decreasing to
115 mV in 5 mM NaCl. The verapamil binding-afﬁnity
increases in parallel with the electrostatic attraction (Fig. 7).
By using surface concentrations, CD,M, instead of bulk con-
centrations, the variation of electrostatic attraction can be ac-
counted for, leading to constant intrinsic binding constant.
The solid lines in Fig. 7 were simulated with similar binding
constants (Kp ¼ 410 6 30 M1; see Table 1). The average
electric charge of verapamil is Æzæ ; 0.85–0.99.
A different situation is encountered for pure POPC bi-
layers. They are noncharged in the absence of verapamil and
becomepositively charged upondrug binding.Under the pres-
ent experimental conditions the surface potentials are small
(c ; 5–15 mV) and the binding constants determined with
and without electrostatic correction differ by ;0–20% only.
The insertion into the hydrophobic membrane entails a dis-
tinct pKa-shift and the electric charge of verapamil in themem-
brane is only Æzæ ; 0.5. The binding constant of the charged
species is Kp ; 400–500 M
1 for LUVs but Kp; 900–1200
for SUVs. Verapamil binding to phosphatidylcholine bila-
yers was determined previously by a centrifugation assay at
22C (1). For multilamellar liposomes composed of egg lec-
ithin (which typically contains 40% POPC), a verapamil par-
tition coefﬁcient of PLipid ; 267 was determined (see also
Fig. 4).
Verapamil binding to POPC LUVs can be compared to
related data obtained for amlodipine and nimodipine leading
to the following order of partition coefﬁcients Kp, for POPC
LUVs (at 37C): verapamil 470 M1, nimodipine; 5.43
103 M1 , amlodipine 7.6 3 103 M1 (see Table 2).
Lipid solubility is a prerequisite for a drug to be
recognized by Pgp, since the active center of this enzyme is
located in the inner part of the lipid membrane. The Pgp ac-
tivity can be measured with a phosphate release assay or,
alternatively, a Cytosensor assay (6). Both assays refer to the
overall process, that is, the binding of the drug from the aque-
ous phase to the active center of the transporter in the lipid
phase. The corresponding free energy, DG0tw, is given by
DG0tw ¼ RT lnðK1Þ, where K1 has been deﬁned above as the
dissociation constant derived from the activation part of the
bell-shaped curve given by Eq. 4. The value DG0tw can be
divided into two physically distinct processes, namely 1), the
partitioning of the drug from water into the lipid membrane,
DG0lw, followed by 2), the binding of the drug to the
transporter in the lipid matrix, DG0tl (6):
DG
0
tw ¼ DG0lw1DG0tl: (15)
DG0lw is related to the lipid-water partition coefﬁcient
according to DG0lw ¼ RT lnKp. In this and previous studies
we have measured Kp by ITC and by surface activity mea-
surements. We thus know DG0lw for all three drugs from
physical-chemical experiments. On the other hand, Pgp acti-
vation has been measured in the present study for verapamil,
amlodipine, and nimodipine with the phosphate release assay
leading to the overall free energyDG0tw (Table 2). Knowledge
of DG0tw and DG
0
lw then allows the evaluation of DG
0
tl, i.e., the
afﬁnity of the drug for the transporter in the lipid phase. The
corresponding results for verapamil, amlodipine, and nimo-
dipine are DG0tl ¼ 4.7, 4.4, and 3.4 kcal/mol, respec-
tively.
DG0tl can be further converted to lipid binding constants and
it is thus possible, for the ﬁrst time, to derive the binding
constants of verapamil and amlodipine to Pgp in the lipid
phase. The corresponding numbers are Ktl ¼ 2.24 3 103 for
verapamil, 1.23 103 for amlodipine, and 230 for nimodipine.
We have previously proposed a model which explains the
substrate versatility of Pgp on the basis of a modular binding
concept, that is, Pgp recognizes well-deﬁned hydrogen-bond
acceptor groups (7). Not all hydrogen-bond acceptor groups
form hydrogen bonds with same free energy. We distinguish
among strong (oxygen atoms), intermediate (nitrogen and
sulfur atoms, phenyl groups), and weak (ﬂuorine atoms)
hydrogen-bond acceptors, weighted with hydrogen-bond
energy units of EUH ¼ 1, 0.5, and 0.25, respectively. This
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model leads to EUH ¼ 5 for verapamil and EUH ¼ 4 for
amlodipine and nimodipine, respectively. Based on the above
free energy of binding in the lipid phase, DG0tl, the average
bonding free energy per hydrogen bond is thus DG0Hi ¼
0:95 kcal=molð1:1 kcal=mol; 0:85 kcal=molÞ for ve-
rapamil (amlodipine, nimodipine). This is in good agreement
with a larger set of 15 drug molecules where the free energy
of binding from water to the transporter was derived from
Cytosensor measurements monitoring the extracellular acid-
iﬁcation rate (see (6), Table 1). The average free energy per
hydrogen bond was found to be DG0Hi  0:79 kcal=mol.
Transport of calcium channel antagonists by Pgp
As Pgp accepts its substrates from the cytosolic leaﬂet, lipid
solubility is an important prerequisite for a substrate to be
recognized by Pgp. The second factor is the binding afﬁnity
of the drug to Pgp determined by the respective hydrogen-
bonding patterns. The above analysis shows that verapamil
exhibits the lowest lipid solubility but has the highest bind-
ing afﬁnity to the transporter. If dissolved at equal concentra-
tions in the lipid phase, verapamil is binding more efﬁciently
than amlodipine or nimodipine. However, if dissolved at equal
concentrations in the aqueous phase, amlodipine and nimo-
dipine are more efﬁcient in saturating Pgp because of their
better lipid solubility. On the other hand, amlodipine and
nimodipine diffuse more rapidly across the lipid membrane
than verapamil due to the smaller cross-sectional area of the
former two. Thus they can escape transport by Pgp more
easily. Nimodipine, moreover, lacks the cationic charge and
is thus not retained at the inner negatively charged membrane
leaﬂet from which Pgp takes its substrates. Nimodipine can
therefore be expected to cross the blood-brain barrier more
easily. Indeed, in animal experiments, nimodipine had a
strong effect on dilating the cerebral arteries, whereas the
other two agonists act mainly on peripheral and cardiac
vessels.
In conclusion, we have provided a complete binding anal-
ysis of verapamil and amlodipine to P-glycoprotein. We
have dissected drug binding into a partitioning step into the
lipid membrane, followed by the actual binding to the Pgp ac-
tive site in the hydrophobic membrane. We could thus deduce
the intrinsic binding constants of verapamil and amlodipine to
Pgp in the lipid phase. All three drugs produce some
disordering of the hydrocarbon chains. However, Pgp is not
deactivated by membrane disordering as proposed previously.
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